Jerome D. Jabbour
2019
In 2019, Jerome D. Jabbour earned a total compensation of $1.3M as Chief Executive Officer at Matinas BioPharma Holdings, a 6% increase compared to previous year.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Option Awards | $680,384 |
| Salary | $444,792 |
| Total | $1,325,176 |
Jabbour received $680.4K in option awards, accounting for 51% of the total pay in 2019.
Jabbour also received $200K in bonus and $444.8K in salary.
Rankings
In 2019, Jerome D. Jabbour's compensation ranked 7,949th out of 13,971 executives tracked by ExecPay. In other words, Jabbour earned more than 43.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,949 out of 13,971 | 43rd |
Division Manufacturing | 3,129 out of 5,695 | 45th |
Major group Chemicals And Allied Products | 1,184 out of 2,194 | 46th |
Industry group Drugs | 1,010 out of 1,880 | 46th |
Industry Pharmaceutical Preparations | 751 out of 1,392 | 46th |
Source: SEC filing on October 1, 2020.
Jabbour's colleagues
We found four more compensation records of executives who worked with Jerome D. Jabbour at Matinas BioPharma Holdings in 2019.
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019